Russian Cancer Drug: Phase II
In a TV interview on the New Year’s Eve the Minister of Healthcare Veronika Skvortsova told on innovative medical developments. In particular, she told about a new cancer drug, fully developed in Russia.
This is a drug of a new class of checkpoint inhibitors used for treatment of cancer. According to Veronika Skvortsova it showed excellent results in treatment of metastating melanomas. Its mechanism of action is based on inhibition of PD-1 antigen using a monoclonal antibody, recovering the ability of the body to detect and kill cancer cells. The drug maintains its effects even when the patient discontinues treatment, as the immune reaction induced continues. It gives a chance to cure.
Phase II clinical studies of the new Russian cancer drug are ongoing.